Standard BioTools has a very small Wall Street following as can be seen above. On average, they expect the company to lose $0 ...

Standard BioTools (LAB) remains unprofitable, with net profit margins flat year-over-year amid a continued rise in annual losses. Losses have averaged a 17.3% increase over the past five years.

STANDARD BIOTOOLS ($LAB) posted quarterly earnings results on Tuesday, May 6th. The company reported earnings of -$0.04 per share, beating estimates of -$0.08 by $0. ...

Good day, everyone, and welcome to Standard BioTools' Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, this conference is being recorded. It's now my pleasure to ...

UMC has received a lab certificate accredited by the College of American Pathologists, a program that focuses on continuous improvement, patient care and safety. They are recognized as the gold ...